ClinicalTrials.Veeva

Menu

Breaking Sitting with High-intensity Interval Training for Brain Health (HIIT2SITLess)

U

University of Illinois at Urbana-Champaign

Status

Enrolling

Conditions

Aging

Treatments

Behavioral: Light-Intensity Interval Training (LIIT) Breaks to Sitting
Behavioral: High-Intensity Interval Training (HIIT) Breaks to Sitting

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06243016
23938
1R21AG080411-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min high intensity interval training (HIIT) breaks compared to light intensity interval training (LIIT) will improve brain health in cognitively normal older adults. This trial will test the feasibility of HIIT breaks to sitting. It will also address several important but unanswered questions: (1) Does interrupting sitting with short HIIT breaks improve frontoparietal function? (2) Can interrupting sitting with HIIT breaks improve cognitive functions?

Full description

The investigators are conducting an acute, single site randomized crossover trial testing two conditions lasting 3.5 hours each with a one to four-weeks washout period: (1) Interrupting sitting with 6 min of high-intensity interval training (HIIT) every 30 min, and (2) interrupting sitting with 6-min light-intensity interval training (LIIT) every 30 min. Investigators will administer the conditions in a counterbalanced order to 54 older adults (40-75 years). Brain function will be assessed using event-related brain potentials and measures of functional connectivity derived from electroencephalography. Cognitive functions will be assessed using a modified Eriksen flanker task and an antisaccade task. Investigators will measure episodic memory using a mnemonic discrimination task.

Enrollment

54 estimated patients

Sex

All

Ages

40 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age 40-75 years
  2. BMI <40 kg/m2
  3. Sedentary (≥ 6 h/day sitting by a survey question)
  4. Physically inactive adults based on the CSEP-PATH: Physical Activity and Sedentayr Behaviour Questionnaire (PASB-Q) Adult (low or medium physical activity range equivalent to less than 300 min of moderate intensity physical activity per week)
  5. Capable of exercising vigorously based on the Physical Activity Readiness Questionnaire (PARQ+)
  6. Has a medical clearance for maximal exercise and HIIT from a physician
  7. Normotensive or participant's blood pressure is controlled
  8. Intelligence quotient (IQ) ≥85
  9. Fasting plasma glucose <126 mg/dL
  10. Good or corrected vision and hearing
  11. Right-handed
  12. No significant abnormalities on the ECG during the maximal exercise test
  13. No signs and symptoms that suggest an underlying cardiovascular disease as recorded during the maximal exercise test by a study physician.
  14. No indications to prematurely stop the maximal exercise test as outlined by the ACSM's Guidelines for Exercise Testing and Prescription
  15. Concussion if more than 12 months before the study screening.
  16. History of cancer but in full remission for at least 12 months and no history of chemotherapy, signed off by the physician or an oncologist

Exclusion criteria

  1. Physical disability or musculoskeletal disease prohibitive to vigorous exercise
  2. Learning disabilities
  3. Cognitive impairment (MoCA <26)
  4. Type 1 or 2 diabetes
  5. Neurological condition (e.g., Multiple Sclerosis, Parkinson, Dementia, Mild Cognitive Impairment)
  6. Color blindness
  7. Brain injury (e.g., traumatic brain injury, stroke, concussion)
  8. Migraine headaches
  9. Presence of other health conditions that may be exacerbated by exercise
  10. History of heart disease
  11. High cholesterol not controlled by medication
  12. Signs and symptoms indicative of underlying cardiovascular disease
  13. A chronic pulmonary disease
  14. Emphysema
  15. Pulmonary embolus
  16. Asthma
  17. History of renal disease
  18. History of seizures
  19. A neuropsychiatric disorder
  20. Osteoporosis if it interferes with an individual's ability to exercise
  21. Severe back problems
  22. Severe arthritis if it interferes with an individual's ability to exercise
  23. Thyroid disorder not controlled by medication
  24. Polyneuropathy
  25. Sleep disorders
  26. Acquired immunodeficiency syndrome (AIDS)
  27. Hepatitis C
  28. History of long Coronavirus Disease 2019 (COVID-19)
  29. History of cancer if not in full remission for at least 12 months and if a participant had the history of chemotherapy
  30. Current or past smoking <12 months
  31. Corticosteroid intake < 31 days before screening
  32. Opioids taken < 6 months from screening
  33. Anabolic androgens taken < 31 days before screening
  34. A serious illness or hospitalization in the last six months
  35. Currently taking medications that can affect the central nervous system (except for anxiolytics)
  36. Current participation in an ongoing trial likely to influence exercise ability or cognitive function

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

54 participants in 2 patient groups

High-Intensity Interval Training (HIIT) Breaks
Active Comparator group
Description:
Sitting interrupted every 30 min by 6-min HIIT bouts.
Treatment:
Behavioral: High-Intensity Interval Training (HIIT) Breaks to Sitting
Light-Intensity Interval Training (HIIT) Breaks
Sham Comparator group
Description:
Sitting interrupted every 30 min by 6-min LIIT bouts.
Treatment:
Behavioral: Light-Intensity Interval Training (LIIT) Breaks to Sitting

Trial contacts and locations

1

Loading...

Central trial contact

Dominika M Pindus, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems